Department of Health and Human Services
National Institutes of Health
Notice is hereby given of a change in the meeting of the Oncology 2—Translational Clinical Integrated Review Group, Translational Immuno-oncology Study Section, October 15, 2026, 09:00 a.m. to October 16, 2026, 06:30 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on September 01, 2026, 91 FR 56151, Doc. No. 2026-17896.
This meeting is being amended to change the meeting from a 2-day to a 1-day meeting on October 15, 2026. And the start time to change from 9 a.m. to 8:30 a.m. The meeting is closed to the public.
Dated: September 10, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.